PUBLICATION

Zebrafish chemical screening reveals the impairment of dopaminergic neuronal survival by cardiac glycosides

Authors
Sun, Y., Dong, Z., Khodabakhsh, H., Chatterjee, S., and Guo, S.
ID
ZDB-PUB-120510-12
Date
2012
Source
PLoS One   7(4): e35645 (Journal)
Registered Authors
Dong, Zhiqiang, Guo, Su
Keywords
none
MeSH Terms
  • Animals
  • Antioxidants/pharmacology
  • Cardenolides/chemistry
  • Cardenolides/pharmacology
  • Cardiac Glycosides/chemistry
  • Cardiac Glycosides/pharmacology*
  • Cell Survival/drug effects
  • Dopaminergic Neurons/cytology
  • Dopaminergic Neurons/drug effects*
  • Dopaminergic Neurons/metabolism
  • Embryo, Nonmammalian/drug effects
  • Embryo, Nonmammalian/metabolism
  • Humans
  • Oxidative Stress
  • Sodium-Potassium-Exchanging ATPase/metabolism
  • Tumor Suppressor Protein p53/antagonists & inhibitors
  • Tumor Suppressor Protein p53/genetics
  • Tumor Suppressor Protein p53/metabolism
  • Zebrafish/growth & development
PubMed
22563390 Full text @ PLoS One
Abstract

Parkinson's disease is a neurodegenerative disorder characterized by the prominent degeneration of dopaminergic (DA) neurons among other cell types. Here we report a first chemical screen of over 5,000 compounds in zebrafish, aimed at identifying small molecule modulators of DA neuron development or survival. We find that Neriifolin, a member of the cardiac glycoside family of compounds, impairs survival but not differentiation of both zebrafish and mammalian DA neurons. Cardiac glycosides are inhibitors of Na+/K+ ATPase activity and widely used for treating heart disorders. Our data suggest that Neriifolin impairs DA neuronal survival by targeting the neuronal enriched Na+/K+ ATPase α3 subunit (ATP1A3). Modulation of ionic homeostasis, knockdown of p53, or treatment with antioxidants protects DA neurons from Neriifolin-induced death. These results reveal a previously unknown effect of cardiac glycosides on DA neuronal survival and suggest that it is mediated through ATP1A3 inhibition, oxidative stress, and p53. They also elucidate potential approaches for counteracting the neurotoxicity of this valuable class of medications.

Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping